What is CRISPR Therapeutics's price / book?

CRISPR Therapeutics (CRSP) reported price / book of 2.5× in Q1 2026.

How has CRISPR Therapeutics's price / book changed year-over-year?

CRISPR Therapeutics's price / book increased by 57.7% year-over-year, from 1.6× to 2.5×.

What is the long-term trend for CRISPR Therapeutics's price / book?

Over 5 years (2020 to 2025), CRISPR Therapeutics's price / book has grown at a -18.1% compound annual growth rate (CAGR), from 7× to 2.6×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

CRISPR Therapeutics CRSP Price / book

Price / book at other companies

CG OncologyCGON

5.2×+2.6×

Cogent Biosciences, Inc.COGT

10.3×+7.2×

Arrowhead ResearchARWR

14.3×+11.7×

Krystal Biotech, Inc.KRYS

5.9×+0.6×

Spyre Therapeutics, Inc.SYRE

5.9×+3.9×

RevvityRVTY

1.4×-0.3×

Other financials

Income statement

See full

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

See full

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Total assets$2.7B+25.8%

Cash flow

See full

Operating cash flow-$108.9M-102%

CapEx$504.0K+145%

Free cash flow-$109.4M-102%

Valuation

See full

Market cap$5.33B+56.4%

Enterprise value$5.69B+69.8%

P/S1,298.3×+1,208×

Profitability

See full

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

See full

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Calculated from CRISPR Therapeutics’s reported figures.

market cap/total stockholders equity=2.5×

Based on the most recent quarter.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CRISPR Therapeutics's price / book?: CRISPR Therapeutics (CRSP) reported price / book of 2.5× in Q1 2026.
How has CRISPR Therapeutics's price / book changed year-over-year?: CRISPR Therapeutics's price / book increased by 57.7% year-over-year, from 1.6× to 2.5×.
What is the long-term trend for CRISPR Therapeutics's price / book?: Over 5 years (2020 to 2025), CRISPR Therapeutics's price / book has grown at a -18.1% compound annual growth rate (CAGR), from 7× to 2.6×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.